Evaluation of the Hepatoprotective Efficacy of Mimusops elengi L. Fruits in a Carbon Tetrachloride-induced Rat Model
- 1 September 2026
- journal article
- Published by Bentham Science Publishers Ltd. in The International Journal of Gastroenterology and Hepatology Diseases
- Vol. 05 (1) , 1-12
Abstract
Introduction: Liver diseases are a major global health burden, and oxidative stress plays a key role in the development of hepatocellular injury. Mimusops elengi L. fruits contain bioactive phytochemicals with reported antioxidant properties. This study aimed to evaluate the hepatoprotective activity of aqueous Mimusops elengi fruit extract against carbon tetrachloride (CCl4)-induced liver injury in Wistar rats. Methods: Male Wistar rats were randomly allocated into five groups (n = 5). Hepatic injury was induced using CCl4 (1 mL/kg, i.p.) for 15 days. Animals received Mimusops elengi fruit extract (200 and 400 mg/kg, orally) or silymarin (25 mg/kg). Serum ALT, AST, and catalase activity were evaluated, followed by histopathological examination of liver tissues. Results: CCl4 administration significantly increased serum ALT and AST levels while reducing catalase activity, indicating severe hepatic injury. Treatment with Mimusops elengi fruit extract significantly reduced liver enzyme levels and improved antioxidant status in a dose-dependent manner. Histopathological examination demonstrated preservation of hepatic architecture, reduced necrosis and decreased inflammatory changes, particularly at 400 mg/kg. Discussion: The hepatopr tective activity observed may be attributed to the antioxidant and membrane- stabilizing properties of flavonoids, tannins, and saponins present in Mimusops elengi fruits. The biochemical and histopathological findings collectively support the traditional medicinal use of this plant for liver protection and suggest its potential as a natural hepatoprotective agent. Conclusion: Mimusops elengi fruit extract exhibits significant hepatoprotective effects against CCl4-induced liver injury, likely mediated through antioxidant mechanisms. These findings support its potential as a natural therapeutic agent, although further studies are required to elucidate its active constituents and molecular pathways.Keywords
This publication has 68 references indexed in Scilit:
- Synergistic hepatoprotection mediated by Tangeretin in Naregamia alata: in vivo and in vitro evidencesCytotechnology, 2026
- Morin: a promising hepatoprotective agent against drug and chemical-induced liver injuryNaunyn-Schmiedeberg's Archives of Pharmacology, 2025
- Hepatoprotective Potential of Phyllanthus niruri Extracts Against CCl4‐Induced Liver Injury in Rats: Insight From Phytochemical Profiling, Molecular Docking, and Oxidative Stress StudiesChemistry & Biodiversity, 2025
- Metformin alleviates doxorubicin-induced hepatic damage by modulating oxidative stress: a molecular, biochemical, and histopathological approach in a rat modelNaunyn-Schmiedeberg's Archives of Pharmacology, 2025
- Pathophysiology of diabetic hepatopathy and molecular mechanisms underlying the hepatoprotective effects of phytochemicalsBiomedicine & Pharmacotherapy, 2023
- Hepatoprotective role of myricitrin isolated from Mimusops elengi Linn. leaves extract on γ‐radiation‐induced liver damage in rats: Phyto‐biochemical investigationsCell Biochemistry and Function, 2023
- Combinatorial Herbal Extracts Alleviate Alcohol-Induced Hepatic DisordersPlant Foods for Human Nutrition, 2023
- Recent insights into the hepatoprotective potential of medicinal plants and plant‐derived compoundsPhytotherapy Research, 2023
- Preventive and therapeutic use of herbal compounds against doxorubicin induced hepatotoxicity: a comprehensive reviewNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Ccl4-Induced Toxicity in Isolated Hepatocytes: the Importance of Direct Solvent InjuryHepatology, 1986